Jenoptik Ag · XETR:JEN

Jenoptik — Merger or Acquisition (October 2021)

14 slides from Jenoptik's merger presentation, October 2021

  1. Slide 1: Jenoptik to acquire Berliner Glas Medical and SwissOptic

    Jenoptik to acquire Berliner Glas Medical and SwissOptic October 2021 © Copyright Jenoptik. All rights reserved.

  2. Slide 2: Disclaimer

    Disclaimer This presentation can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the

  3. Slide 3: Strengthening global photonics business

    Strengthening global photonics business Jenoptik to acquire Berliner Glas Medical and SwissOptic: - Accelerated growth and stronger focus on photonics - Expansion of global presence in attractive markets (semicon, medical) - Broadening of customer and product portfolio October 2021 3

  4. Slide 4: Berliner Glas Medical / SwissOptic at a glance

    Berliner Glas Medical / SwissOptic at a glance 1 ~70 Key markets: Substantial Highly years of high Medical technology expansion reputable precision optics Semiconductor of combined global premium product experience Metrology production facilities provider ~500 ~130m euros >10% Attractive Mid-term em

  5. Slide 5: Berliner Glas Medical / SwissOptic detailed overview

    Berliner Glas Medical / SwissOptic detailed overview 1 Medical Medical Metrology Other Semicon Intraoral Intraoral Robotic Robotic Life Scanners Surgery Ophthalmology Surveying Industrial Customer-specific solutions Scanners Surgery Sciences ~7% Share of ~23% ~42% revenue1 ~11% ~17% Product Examples

  6. Slide 6: Transaction rationale and highlights

    Berliner Glas Medical / SwissOptic acquisition – Transaction rationale and highlights 1 Strengthening of Jenoptik’s global photonics / L&O business 2 Footprint expansion in highly attractive markets – particularly medical technology and semicon 3 Broadening of product and technology offering 4 Expan

  7. Slide 7: Strengthening of Jenoptik's global photonics / L&O business

    1 Strengthening of Jenoptik’s global photonics / L&O business Pro-forma Jenoptik revenue share by division1) Jenoptik revenue share by division1) (incl. Berliner Glas Medical and SwissOptic) Photonics 82% Light & Optics Light & Production Light Light&& 41% Production Production 21% 12% 51% 13% 23% L

  8. Slide 8: Footprint expansion in highly attractive markets – particularly semicon and medical technology

    Footprint expansion in highly attractive markets – particularly semicon and 2 medical technology crypt# Medical Medical Metrology Semicon Other Intraoral Robotic Life Ophthalmology Surveying Industrial Scanners Surgery Sciences • Rising demand for • Aging population and • Structurally growing • Incr

  9. Slide 9: Broadening of product and technology offering

    3 Broadening of product and technology offering Medical Technology Semicon Jenoptik’s existing medical technology Strengthening offering for major semicon customers business will almost double − Complementary product portfolios resulting in a comprehensive combined − Berliner Glas Medical adds two n

  10. Slide 10: Expansion of global manufacturing footprint incl. China

    4 Expansion of global manufacturing footprint incl. China Berlin, Germany Heerbrugg, Switzerland Wuhan, China 3 additional ~110 FTE ~290 FTE ~100 FTE production facilities Expansion of combined production area incl. cleanroom capacity ~500 employees − Significant growth potential for Jenoptik from S

  11. Slide 11: Upside potential through well-defined synergy opportunities

    5 Upside potential through well-defined synergy opportunities Procurement Production optimization Cost synergy potential via joint procurement Additional production capacity to optimize (higher volumes) utilization levels across production footprint Research & Development Wuhan facility More efficie

  12. Slide 12: Highly attractive deal economics and sustainable profitable growth

    6 Highly attractive deal economics and sustainable profitable growth ~300m euros Accretive Accelerated Attractive purchase price In 2022 growth profile margin profile Financing ~3x Dec 2021 with cash on balance post-acquisition expected closing, after sheet and undrawn leverage, still in line approv

  13. Slide 13: Acquisition accelerates growth and strengthens Jenoptik's market position

    Acquisition accelerates growth and strengthens Jenoptik’s market position as a leading global photonics group Accelerating transition into a focused photonics player Expanding our technological leadership Building a truly global enterprise Promising growth opportunities October 2021 13

  14. Slide 14: Thank you for your attention!

    Thank you for your attention! x © Copyright Jenoptik. All rights reserved.

Jenoptik — Merger or Acquisition (October 2021) on 6ix